SAN CLEMENTE, Calif., Feb. 27, 2017 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced that Company management will present at the Raymond James 38th Annual Institutional Investors Conference in Orlando, Florida.
ICU Medical’s presentation will take place on Wednesday, March 8th at 9:50 AM Eastern Time.
The presentation will be webcast live and can be accessed by going to the Company's website at http://www.icumed.com, clicking on the Investors tab and clicking on the Event Calendar tab. The webcast will also be available by replay.
About ICU Medical, Inc.
About ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. ICU Medical's products improve patient outcomes by helping prevent bloodstream infections and protecting healthcare workers from exposure to infectious diseases or hazardous drugs. The company's complete product line includes custom IV systems, closed delivery systems for hazardous drugs, needle-free IV connectors, catheters and cardiac monitoring systems. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical, Inc. can be found at www.icumed.com.
CONTACT: ICU Medical, Inc. Scott Lamb, Chief Financial Officer (949) 366-2183 ICR, Inc. John Mills, Partner (646) 277-1254


Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow
Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push
Anthropic CEO Meets Trump Officials to Discuss Powerful New AI Model Mythos
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks
How Technology Is Reshaping Modern Business: From Operations to Customer Experience
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs
Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries” 



